Dov Elefant Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dov Elefant.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dov Elefant. Dov Elefant is a Controller - VP - Fin & Admin in IMMUNE PHARMACEUTICALS INC ($IMNP) and a Chief Financial Officer in Cellectar Biosciences, Inc. ($CLRB) and a Chief Financial Officer in Akari Therapeutics Plc ($AKTX).
Address: C/O EPICEPT CORPORATION 270 SYLVAN AVENUE ENGLEWOOD CLIFFS 07632 NJ
Companies in which Dov Elefant is an Insider
Akari Therapeutics Plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dov Elefant: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 22 2015
$AKTX Market Capitalization: $82.90M
$AKTX Previous Close: $7.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cellectar Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dov Elefant: Chief Financial Officer
Holdings: 11,755 shares
Current Value: $19,631
Latest Transaction: Mar 05 2021
$CLRB Market Capitalization: $9.82M
$CLRB Previous Close: $1.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dov Elefant: Controller - VP - Fin & Admin
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 09 2006
$IMNP Market Capitalization: $23.82M
$IMNP Previous Close: $0.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Dov Elefant
Sentiment: All, AKTX, CLRB, IMNP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Option Exercise | A | 1.74 | 430,000 | 748,200 | 430,000 | |
| Dec 28 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Buy | P | 1.35 | 7,407 | 9,999 | 11,755 | 4.3 K to 11.8 K (+170.35 %) |
| Jun 08 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Option Exercise | P | 1.21 | 2,174 | 2,625 | 2,174 | |
| Jun 08 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Buy | P | 1.15 | 4,348 | 4,978 | 4,348 | 0 to 4.3 K |
| Feb 04 2020 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Grant | A | 2.71 | 10,000 | 27,100 | 10,000 | 0 to 10 K |
| Sep 11 2019 | CLRB | Cellectar Bioscien ... | Elefant Dov | Chief Financial Off ... | Option Exercise | A | 2.32 | 90,000 | 208,800 | 90,000 | |
| Sep 22 2015 | AKTX | Akari Therapeutics ... | Elefant Dov | Chief Financial Off ... | Option Exercise | A | 0.32 | 4,067,963 | 1,310,291 | 4,067,963 |